Jan 13 (Reuters) - Chr Hansen Holding A/S CHRH.CO :
* CHR. HANSEN HOLDING A/S INTERIM REPORT Q1 2021/22
* OUTLOOK 2021/22: OUTLOOK FOR 2021/22 REMAINS UNCHANGED
FROM
ORIGINAL GUIDANCE PROVIDED ON OCTOBER 14, 2021
* Q1 REVENUE EUR 268 MILLION VERSUS COMPANY COMPILED
CONSENSUS OF
EUR 255 MILLION
* OUTLOOK 2021/22: ORGANIC GROWTH IS EXPECTED IN RANGE OF
5-8%.
* Q1 EBIT EUR 65 MILLION VERSUS COMPANY COMPILED CONSENSUS
OF EUR
64 MILLION
* OUTLOOK 2021/22: EBIT MARGIN BEFORE SPECIAL ITEMS IS
EXPECTED TO
BE 27-28%.
* OUTLOOK 2021/22: FREE CASH FLOW BEFORE SPECIAL ITEMS IS
EXPECTED
TO BE AROUND EUR 140-170 MILLION.
* UNDER ITS 2025 STRATEGY, CHR. HANSEN WILL CONTINUE ITS
JOURNEY
AS A DIFFERENTIATED BIOSCIENCE COMPANY FOCUSED ON MICROBIAL AND
FERMENTATION TECHNOLOGY PLATFORMS
* Q1 NET PROFIT EUR 46.2 MILLION VERSUS COMPANY COMPILED
CONSENSUS
OF EUR 44 MILLION
* THE LONG-TERM FINANCIAL AMBITIONS FOR THE PERIOD TO
2024/25 WERE
UPDATED TO REFLECT THE DIVESTMENT OF NATURAL COLORS AND THE
ACQUISITION OF JENNEWEIN (HMO ACTIVITIES)
* CHR. HANSEN REMAINS COMMITTED TO DELIVERING
INDUSTRY-LEADING
PROFITABLE GROWTH AND STRONG CASH FLOWS WITH THE FOCUS ON COST
DISCIPLINE AND CAPITAL EFFICIENCY
* Q1 ORGANIC GROWTH OF 9% VERSUS COMPANY COMPILED CONSENSUS
OF
4.4%
Source text for Eikon: ID:nGNE46kkrL
Further company coverage: CHRH.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))